Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.
D000374:Aggression / Q000187:drug effects; D000568:Amenorrhea / Q000139:chemically induced; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D010169:Palmitic Acids / Q000627:therapeutic use; D010640:Phenothiazines; D010880:Piperidines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011247:Pregnancy; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D014476:Undecylenic Acids / Q000627:therapeutic use
D014150:Antipsychotic Agents; D010169:Palmitic Acids; D010640:Phenothiazines; D010880:Piperidines; D013449:Sulfonamides; D014476:Undecylenic Acids